Raquel Aguilar-Rosales

Ms. Raquel Aguilar-Rosales

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2026 in Archives of Microbiology
Verified
Journal Article
Open access
PDF file
Raquel Aguilar-RosalesRaquel Aguilar-Rosales
Raquel Aguilar-Rosales
AEAlma Reyna Escalona-Montaño
Alma Reyna Escalona-Montaño
AGAna Pamela Gómez-García
Ana Pamela Gómez-García
DSDaniel Andrés Sánchez-Almaraz
Daniel Andrés Sánchez-Almaraz
MLMartha Legorreta-Herrera
Martha Legorreta-Herrera
MAMaria Magdalena Aguirre-Garcia
Maria Magdalena Aguirre-Garcia
Interactions between parasites and the gut microbiota play a key role in immune responses and susceptibility to zoonotic diseases; however, many aspects of how protozoan infections alter microbial diversity and how these changes influence parasite pathogenicity and host defense remain poorly understood. This review integrates recenst studies using murine models of the Muroidea superfamily, highlighting patterns in microbial diversity, functional interactions, and potential immunometabolic mechanisms underlying these relationships. Both consistent findings and discrepancies among studies are identified, reflecting differences in parasite species, experimental models, and infection conditions. Unlike previous work, this review emphasizes the link between microbiota alterations, infection progression, and host responses. Finally, these findings are integrated to provide an interpretive framework that advances our understanding of how the microbiota modulates infection dynamics and identifies key knowledge gaps that warrant further investigation.

Verified
Journal Article
Open access
PDF file
SRSandra Angélica Rojas-Osornio
Sandra Angélica Rojas-Osornio
VPVladimir Paredes-Cervantes
Vladimir Paredes-Cervantes
MAMaria Magdalena Aguirre-Garcia
Maria Magdalena Aguirre-Garcia
MCMinerva PEREZ Crespo
Minerva PEREZ Crespo
CMClaudia Cecilia Mota
Claudia Cecilia Mota
ETEmiliano Tesoro-Cruz
Emiliano Tesoro-Cruz
The gut microbiota produces molecules that trigger responses at the local and distant levels. It affects the brain through several metabolic products, including serotonin (5-HT). Tryptophan hydroxylase type 1 (Tph1) is the rate-limiting enzyme during 5-HT biosynthesis in the gut. Efavirenz (EFV), an antiretroviral agent against HIV, is associated with depression disorders and Tryptophan hydroxylase type 2 (Tph2) deregulation in mice. The possible association between the depressive effects of EFV secondary to dysbiosis and the expression of Tph1 in the intestine is yet to be studied. Therefore, we aimed to elucidate the role of the gut microbiota in depression mechanisms. We reviewed the gut microbiota, their metabolites (short-chain fatty acids [SCFA]), Tph1 expression in the gut, and systemic 5-HT and tryptophan levels in CD1 mice after 36 days of oral EFV (10 mg/kg) treatment. The proportions of Bacteroidota and Bacillota_A_368345 decreased and increased, respectively, following EFV treatment. Additionally, the abundance of Lactobacillus spp. and Faecalbaculum decreased, whereas that of Dubosiella spp., Blautia_A_141780, and Anaerostipes increased. These bacteria contribute to SCFA production and may have counteracted the lack of protective effects provided by Lactobacillus. Tph1 expression was dysregulated in the gut, whereas serum 5-HT levels decreased following EFV treatment. Lactobacillus species promote 5-HT production in the gut, and the deregulation of Tph1 affects 5-HT synthesis. This disruption in the gut–brain axis decreased peripheral 5-HT levels. This affects the serotonergic system in the brain, which could contribute to depression.